-
1-{10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethan-1-one; but-2-enedioic acid
-
ChemBase ID:
154679
-
Molecular Formular:
C23H26N2O5S
-
Molecular Mass:
442.52794
-
Monoisotopic Mass:
442.15624294
-
SMILES and InChIs
SMILES:
CC(=O)c1ccc2c(c1)N(c1ccccc1S2)CCCN(C)C.C(=C\C(=O)O)/C(=O)O
Canonical SMILES:
OC(=O)/C=C/C(=O)O.CN(CCCN1c2ccccc2Sc2c1cc(cc2)C(=O)C)C
InChI:
InChI=1S/C19H22N2OS.C4H4O4/c1-14(22)15-9-10-19-17(13-15)21(12-6-11-20(2)3)16-7-4-5-8-18(16)23-19;5-3(6)1-2-4(7)8/h4-5,7-10,13H,6,11-12H2,1-3H3;1-2H,(H,5,6)(H,7,8)
InChIKey:
FQRHOOHLUYHMGG-UHFFFAOYSA-N
-
Cite this record
CBID:154679 http://www.chembase.cn/molecule-154679.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
1-{10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethan-1-one; but-2-enedioic acid
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
2-Acetyl-10-(3-dimethylaminopropyl)phenothiazine maleate salt
|
Acepromazine maleate salt
|
Acetopromazine maleate salt
|
Acepromazine maleate
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
16.055948
|
H Acceptors
|
3
|
H Donor
|
0
|
LogD (pH = 5.5)
|
0.6094632
|
LogD (pH = 7.4)
|
2.3599155
|
Log P
|
3.488603
|
Molar Refractivity
|
99.3543 cm3
|
Polarizability
|
37.856915 Å3
|
Polar Surface Area
|
23.55 Å2
|
Rotatable Bonds
|
7
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
A7111
|
Application Acepromazine is a phenothiazine and an analogue of the antipsychotic drug chlorpromazine (Cat. No. C8138). Acepromazine is thought to block dopamine receptors in the brain, and inhibit ABCG2 transport protein whose overexpression in tumors is associated with drug resistance. Biochem/physiol Actions Acepromazine is a phenothiazine antipsychotic comonly used as a veterinary drug (horses, dogs and cats). The compound is an analogue antipsychotic drug chlorpromazine (#C8138). The drug is thought to block receptors of dopamine in the brain. Recently it was discover that the compound inhibits ABCG2 transported protein, which overexpression in tumors is associated with drug resistance. |
PATENTS
PATENTS
PubChem Patent
Google Patent